BACMINE SL

Their core work

BACMINE SL is a Spanish biotech SME based in Tres Cantos — Spain's pharmaceutical and life sciences cluster near Madrid — specializing in industrial microbiology and synthetic biology. Their most substantial EU work centers on engineering the soil bacterium Pseudomonas putida to metabolize plastic waste and convert it into biodegradable polymers and other value-added compounds, a field at the intersection of biotechnology, circular economy, and materials science. They also have secondary exposure to sustainable aquaculture, likely contributing microbial or fermentation-related expertise. The company name itself ("BACMINE") suggests their core identity: extracting value from bacterial systems — bioprospecting, biocatalysis, or microbial mining of useful compounds.

What they specialise in

How they've shifted over time

BACMINE's H2020 participation is limited to two projects launched within two years of each other (2015 and 2017), so a long-term evolution is difficult to establish. Their primary bet was clearly on synthetic biology for plastic biodegradation — a high-value, high-complexity topic that dominated the 2015–2019 period. The SAFE-Aqua involvement appears to be a secondary or exploratory move into sustainable agriculture, possibly testing whether their microbial expertise could transfer to aquaculture systems. No keyword data is available to sharpen this analysis further.

BACMINE appears to be probing adjacent markets for their microbial expertise — moving from industrial plastic upcycling toward biological solutions in food and aquaculture — but the data is too thin to confirm a sustained strategic shift.

How they like to work

BACMINE has participated exclusively as a consortium partner, never taking a coordinating role, which is typical for a small specialist SME contributing a defined technical capability rather than driving project strategy. They worked across 15 partners in 7 countries from just 2 projects, suggesting they integrate into mid-to-large international consortia. This profile — focused contributor in diverse, multinational teams — makes them a reliable specialist rather than a project driver.

BACMINE has built a surprisingly broad network for a 2-project participant: 15 unique partners across 7 countries, driven largely by the P4SB consortium which was a major RIA project. Their geographic footprint is European, with likely connections to German, UK, Dutch, and Nordic research and industrial partners common in synthetic biology consortia of that era.

What sets them apart

BACMINE occupies a rare niche as a Spanish SME with hands-on synthetic biology expertise applied to industrial biotechnology — a space dominated by large research institutes and universities. Their Tres Cantos base places them inside Spain's densest biotech cluster, close to pharmaceutical multinationals and CSIC research centers, which likely shapes their applied rather than purely academic orientation. For a consortium needing a small, agile biotech partner with genuine wet-lab microbial engineering capabilities and Spanish industry connections, BACMINE fits a profile that is hard to find at SME scale.

Highlights from their portfolio

• P4SB
  BACMINE's flagship EU project — a €6M+ RIA that tackled plastic-to-value bioconversion using Pseudomonas putida synthetic biology, representing 97% of their total EC funding and their clearest technical signature.
• SAFE-Aqua
  A smaller MSCA-RISE mobility project that hints at BACMINE's interest in expanding into sustainable food systems, though their role was peripheral given the €22,500 contribution.